Oncology News and Research

RSS
Researchers make significant advance in treatment of bowel cancer

Researchers make significant advance in treatment of bowel cancer

Many cancer patients' ED visits could be avoided with better symptom management, timely care

Many cancer patients' ED visits could be avoided with better symptom management, timely care

Small clinical trial reveals promising results of triple immunotherapy in treating rare skin cancer

Small clinical trial reveals promising results of triple immunotherapy in treating rare skin cancer

Radiopharmaceutical for cancer diagnosis is ready for preclinical-phase trial

Radiopharmaceutical for cancer diagnosis is ready for preclinical-phase trial

Children suffering from IBD not meeting daily recommended intake of calcium and vitamin D

Children suffering from IBD not meeting daily recommended intake of calcium and vitamin D

FDA issues Complete Response Letter for Sunovion’s New Drug Application to treat COPD patients

FDA issues Complete Response Letter for Sunovion’s New Drug Application to treat COPD patients

Dragon Master Foundation to fund DIPG trial that will make patient data available live in the cloud

Dragon Master Foundation to fund DIPG trial that will make patient data available live in the cloud

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

Biovica appoints Samuel Rotstein as Scientific Advisor

Biovica appoints Samuel Rotstein as Scientific Advisor

Combined use of two existing drugs appears to slow cancer's tendency to spread, study shows

Combined use of two existing drugs appears to slow cancer's tendency to spread, study shows

Study reveals how enzyme allows brain tumors to grow despite harsh surroundings

Study reveals how enzyme allows brain tumors to grow despite harsh surroundings

Immunotherapy can be more effective in NSCLC patients who received radiation therapy, study shows

Immunotherapy can be more effective in NSCLC patients who received radiation therapy, study shows

NCCN ORP funds researchers to evaluate targeted treatment in EGFRm+ non-small cell lung cancer

NCCN ORP funds researchers to evaluate targeted treatment in EGFRm+ non-small cell lung cancer

Study: Early-stage breast cancer patients undergo inappropriate tests that may increase financial burden

Study: Early-stage breast cancer patients undergo inappropriate tests that may increase financial burden

Men appear to have worse chemotherapy-induced cardiomyopathy than women, research shows

Men appear to have worse chemotherapy-induced cardiomyopathy than women, research shows

Feinstein Institute honors Sir Paul Nurse with Cerami Award for cancer research

Feinstein Institute honors Sir Paul Nurse with Cerami Award for cancer research

Study establishes link between sedentary lifestyle and kidney, bladder cancer risk

Study establishes link between sedentary lifestyle and kidney, bladder cancer risk

New book provides latest information on palliative care organization and delivery

New book provides latest information on palliative care organization and delivery

New study offers insight into how to improve chemotherapy strategies for ovarian cancer

New study offers insight into how to improve chemotherapy strategies for ovarian cancer

Study points to new pharmacologic approach to target chemo-resistant lung cancer

Study points to new pharmacologic approach to target chemo-resistant lung cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.